Profile Image
Joseph Clark Photo
Name
Joseph Clark
Degree
M.D.
FACP
Rank
Professor
Primary Department
Hematology/Oncology
Appointment Request
Request an Appointment
Specialties
Kidney Cancer
Melanoma
Head and Neck Cancer
Locations
Cardinal Bernardin Cancer Center
Certifications
American Board of Internal Medicine Subspecialty Medical Oncology
Education
Medical School
Loyola University Chicago Stritch School of Medicine
Residencies
Loyola University Medical Center, Internal Medicine: General
Fellowships
Fox Chase Cancer Center/Temple University Hospital, Hematology & Medical Oncology
Hobbies
Triathlon
Reading
Travel
Keywords
Cancer/Carcinogenesis
Chemotherapeutic Agents
Cytokines
Immune System
Immunotherapy
Interferon
Melanoma
Vaccine
Publications
Moore,T.; Wagner,C. R.; Scurti,G. M.; Hutchens,K. A.; Godellas,C.; Clark,A. L.; Kolawole,E. M.; Hellman,L. M.; Singh,N. K.; Huyke,F. A.; Wang,S. Y.; Calabrese,K. M.; Embree,H. D.; Orentas,R.; Shirai,K.; Dellacecca,E.; Garrett-Mayer,E.; Li,M.; Eby,J. M.; Stiff,P. J.; Evavold,B. D.; Baker,B. M.; Le Poole,I. C.; Dropulic,B.; Clark,J. I.; Nishimura,M. I.Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Cancer immunology, immunotherapy : CII 2018 ;67(2):327-017-2102-z
Moore,T.; Wagner,C. R.; Scurti,G. M.; Hutchens,K. A.; Godellas,C.; Clark,A. L.; Kolawole,E. M.; Hellman,L. M.; Singh,N. K.; Huyke,F. A.; Wang,S. Y.; Calabrese,K. M.; Embree,H. D.; Orentas,R.; Shirai,K.; Dellacecca,E.; Garrett-Mayer,E.; Li,M.; Eby,J. M.; Stiff,P. J.; Evavold,B. D.; Baker,B. M.; Le Poole,I. C.; Dropulic,B.; Clark,J. I.; Nishimura,M. I.Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Cancer immunology, immunotherapy : CII 2018 ;67(2):311-325
Clark,J. I.; Wong,M. K.; Kaufman,H. L.; Daniels,G. A.; Morse,M. A.; McDermott,D. F.; Agarwala,S. S.; Lewis,L. D.; Stewart,J. H.; Vaishampayan,U.; Curti,B.; Gonzalez,R.; Lutzky,J.; Rudraptna,V.; Cranmer,L. D.; Jeter,J. M.; Hauke,R. J.; Miletello,G.; Milhem,M. M.; Amin,A.; Richart,J. M.; Fishman,M.; Hallmeyer,S.; Patel,S. P.; Van Veldhuizen,P.; Agarwal,N.; Taback,B.; Treisman,J. S.; Ernstoff,M. S.; Perritt,J. C.; Hua,H.; Rao,T. B.; Dutcher,J. P.; Aung,S.Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM CLINICAL GENITOURINARY CANCER 2017 ;15(1):31-41.e4
Alva,A.; Daniels,G. A.; Wong,M. K.; Kaufman,H. L.; Morse,M. A.; McDermott,D. F.; Clark,J. I.; Agarwala,S. S.; Miletello,G.; Logan,T. F.; Hauke,R. J.; Curti,B.; Kirkwood,J. M.; Gonzalez,R.; Amin,A.; Fishman,M.; Agarwal,N.; Lowder,J. N.; Hua,H.; Aung,S.; Dutcher,J. P.Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma Cancer immunology, immunotherapy : CII 2016 ; :
Klarquist,J.; Tobin,K.; Farhangi Oskuei,P.; Henning,S. W.; Fernandez,M. F.; Dellacecca,E. R.; Navarro,F. C.; Eby,J. M.; Chatterjee,S.; Mehrotra,S.; Clark,J. I.; Le Poole,I. C.Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma Cancer research 2016 ; :
Buchbinder,E. I.; Gunturi,A.; Perritt,J.; Dutcher,J.; Aung,S.; Kaufman,H. L.; Ernstoff,M. S.; Miletello,G. P.; Curti,B. D.; Daniels,G. A.; Patel,S. P.; Kirkwood,J. M.; Hallmeyer,S.; Clark,J. I.; Gonzalez,R.; Richart,J. M.; Lutzky,J.; Morse,M. A.; Sullivan,R. J.; McDermott,D. F.A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma Journal for immunotherapy of cancer 2016 ;4:52-016-0155-8. eCollection 2016
Block,A. M.; Alite,F.; Diaz,A. Z.; Borrowdale,R. W.; Clark,J. I.; Choi,M.Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face Case reports in oncological medicine 2015 ;2015:827608
Jaber,J. J.; Murrill,L.; Clark,J. I.; Johnson,J. T.; Feustel,P. J.; Mehta,V.Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2015 ;153(2):209-217
McDermott,D. F.; Cheng,S. C.; Signoretti,S.; Margolin,K. A.; Clark,J. I.; Sosman,J. A.; Dutcher,J. P.; Logan,T. F.; Curti,B. D.; Ernstoff,M. S.; Appleman,L.; Wong,M. K.; Khushalani,N. I.; Oleksowicz,L.; Vaishampayan,U. N.; Mier,J. W.; Panka,D. J.; Bhatt,R. S.; Bailey,A. S.; Leibovich,B. C.; Kwon,E. D.; Kabbinavar,F. F.; Belldegrun,A. S.; Figlin,R. A.; Pantuck,A. J.; Regan,M. M.; Atkins,M. B.The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma Clinical cancer research : an official journal of the American Association for Cancer Research 2015 ;21(3):561-568
Petruzzelli,G. J.; Howell,J. B.; Pederson,A.; Origitano,T. C.; Byrne,R. W.; Munoz,L.; Emami,B.; Clark,J. I.Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence American Journal of Otolaryngology 2015 ;36(4):547-553
Escudier,B.; Michaelson,M. D.; Motzer,R. J.; Hutson,T. E.; Clark,J. I.; Lim,H. Y.; Porfiri,E.; Zalewski,P.; Kannourakis,G.; Staehler,M.; Tarazi,J.; Rosbrook,B.; Cisar,L.; Hariharan,S.; Kim,S.; Rini,B. I.Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial British journal of cancer 2014 ;110(12):2821-2828
Clark,J. I.; Greene,J. B.; Lau Clark,A.; Dalal,J. S.; Hofmeister,C. C.Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancer MEDICAL ONCOLOGY 2013 ;30(1):358-358
Burroughs,S. L.; Duncan,R. S.; Rayudu,P.; Kandula,P.; Payne,A. J.; Clark,J. L.; Koulen,P.; Kaja,S.Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures Journal of neuroscience methods 2012 ;203(1):141-145
Margolin,K.; Ernstoff,M. S.; Hamid,O.; Lawrence,D.; McDermott,D.; Puzanov,I.; Wolchok,J. D.; Clark,J. I.; Sznol,M.; Logan,T. F.; Richards,J.; Michener,T.; Balogh,A.; Heller,K. N.; Hodi,F. S.Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The lancet oncology 2012 ;13(5):459-465
Jaber,J. J.; Clark,J. I.; Muzaffar,K.; Ruggiero,F. P.; Feustel,P. J.; Frett,M. J.; Zender,C. A.Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience. Head & neck 2011 ;33(1):7-12
Hodi,F. S.; O'Day,S. J.; McDermott,D. F.; Weber,R. W.; Sosman,J. A.; Haanen,J. B.; Gonzalez,R.; Robert,C.; Schadendorf,D.; Hassel,J. C.; Akerley,W.; van den Eertwegh,A. J.; Lutzky,J.; Lorigan,P.; Vaubel,J. M.; Linette,G. P.; Hogg,D.; Ottensmeier,C. H.; Lebbe,C.; Peschel,C.; Quirt,I.; Clark,J. I.; Wolchok,J. D.; Weber,J. S.; Tian,J.; Yellin,M. J.; Nichol,G. M.; Hoos,A.; Urba,W. J.Improved survival with ipilimumab in patients with metastatic melanoma The New England journal of medicine 2010 ;363(8):711-723
Locke,F.; Clark,J. I.; Gajewski,T. F.A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma CANCER CHEMOTHERAPY AND PHARMACOLOGY 2010 ;65(3):509-514
Clark,J. I.; Moon,J.; Hutchins,L. F.; Sosman,J. A.; Kast,W. M.; Da Silva,D. M.; Liu,P. Y.; Thompson,J. A.; Flaherty,L. E.; Sondak,V. K.Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508. Cancer 2010 ;116(2):424-431
Gunturu,K. S.; Meehan,K. R.; Mackenzie,T. A.; Crocenzi,T. S.; McDermott,D.; Usherwood,E. J.; Margolin,K. A.; Crosby,N. A.; Atkins,M. B.; Turk,M. J.; Ahonen,C.; Fuse,S.; Clark,J. I.; Fisher,J. L.; Noelle,R. J.; Ernstoff,M. S.Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(7):1196-1202
Bragg,T. M.; Scianna,J.; Kassam,A.; Emami,B.; Brown,H. G.; Hacein-Bey,L.; Clark,J. I.; Muzaffar,K.; Boulis,N.; Prabhu,V. C.Clinicopathological review: esthesioneuroblastoma Neurosurgery 2009 ;64(4):764-770
Clark,J. I.; Eisner,R. M.; Hofmeister,C.; Norton,J.; Thomas,S.; Choudhury,A.; Petruzzelli,G.; Lathers,D.; Young,M. R.; Lau,A.; Emami,B.Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer. American Journal of Clinical Oncology 2009 ;32(4):396-400
Gordon,M. S.; Hussey,M.; Nagle,R. B.; Lara,P. N.,Jr; Mack,P. C.; Dutcher,J.; Samlowski,W.; Clark,J. I.; Quinn,D. I.; Pan,C. X.; Crawford,D.Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(34):5788-5793
Van Veldhuizen,P. J.; Hussey,M.; Lara,P. N.,Jr; Mack,P. C.; Gandour-Edwards,R.; Clark,J. I.; Lange,M. K.; Crawford,D. E.A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312 American Journal of Clinical Oncology 2009 ;32(5):453-459
Cohen,E. E.; Davis,D. W.; Karrison,T. G.; Seiwert,T. Y.; Wong,S. J.; Nattam,S.; Kozloff,M. F.; Clark,J. I.; Yan,D. H.; Liu,W.; Pierce,C.; Dancey,J. E.; Stenson,K.; Blair,E.; Dekker,A.; Vokes,E. E.Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study The lancet oncology 2009 ;10(3):247-257
Sosman,J. A.; Carrillo,C.; Urba,W. J.; Flaherty,L.; Atkins,M. B.; Clark,J. I.; Dutcher,J.; Margolin,K. A.; Mier,J.; Gollob,J.; Kirkwood,J. M.; Panka,D. J.; Crosby,N. A.; O'Boyle,K.; LaFleur,B.; Ernstoff,M. S.Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 ;26(14):2292-2298
Lee,R. T.; Beekman,K. E.; Hussain,M.; Davis,N. B.; Clark,J. I.; Thomas,S. P.; Nichols,K. F.; Stadler,W. M.A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer CLINICAL GENITOURINARY CANCER 2008 ;6(1):21-24
Levey,S. A.; Bajwa,R. S.; Picken,M. M.; Clark,J. I.; Barton,K.; Leehey,D. J.Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation. NDT Plus 2008 ;3:154-156
Atkins,M. B.; Sosman,J. A.; Agarwala,S.; Logan,T.; Clark,J. I.; Ernstoff,M. S.; Lawson,D.; Dutcher,J. P.; Weiss,G.; Curti,B.; Margolin,K. A.Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study Cancer 2008 ;113(8):2139-2145
Hutchins,L. F.; Moon,J.; Clark,J. I.; Thompson,J. A.; Lange,M. K.; Flaherty,L. E.; Sondak,V. K.Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026. Cancer 2007 ;110(10):2269-2275
Margolin,K.; Atkins,M. B.; Dutcher,J. P.; Ernstoff,M. S.; Smith,J. W.,2nd; Clark,J. I.; Baar,J.; Sosman,J.; Weber,J.; Lathia,C.; Brunetti,J.; Cihon,F.; Schwartz,B.Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. Clinical Cancer Research 2007 ;13(11):3312-3319
Meyer,P. N.; Clark,J. I.; Flanigan,R. C.; Picken,M. M.Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. American Journal of Clinical Pathology 2007 ;128(1):70-79
Clark,J. I.; Mehrabi,J.; Sosman,J. A.; Logan,T. F.; Margolin,K. A.; Dutcher,J. P.; Urba,W. J.; Ernstoff,M. S.; McDermott,D. F.; Lau,A. M.; Atkins,M. B.Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study. Journal of Immunotherapy 2007 ;30(8):839-846
Farray,D.; Clark,J. I.Vaccine therapy of malignant melanoma. Clinical and applied immunology reviews 2006 ;6(3):217
Worden,F. P.; Moon,J.; Samlowski,W.; Clark,J. I.; Dakhil,S. R.; Williamson,S.; Urba,S. G.; Ensley,J.; Hussain,M. H.A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007. Cancer 2006 ;107(2):319-327
Schneck,M. J.; Patel,A.; Rodriguez-Quinonez,A.; Brown,H. G.; Clark,J. I.; Prabhu,V.; Dafer,R. M.; Biller,J.Metastatic Melanoma to the Central Nervous System: Case Report and Review of the Literature Seminars in Cerebrovascular Diseases and Stroke 2005 ;5(3):217-220
Tanvetyanon,T.; Clark,J. I.; Campbell,S. C.; Lo,S. S.Neoadjuvant therapy: an emerging concept in oncology Southern medical journal 2005 ;98(3):338-344
Paner,G. P.; Turk,T. M.; Clark,J. I.; Lindgren,V.; Picken,M. M.Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Archives of Pathology & Laboratory Medicine 2005 ;129(10):1317-1321
McDermott,D. F.; Regan,M. M.; Clark,J. I.; Flaherty,L. E.; Weiss,G. R.; Logan,T. F.; Kirkwood,J. M.; Gordon,M. S.; Sosman,J. A.; Ernstoff,M. S.; Tretter,C. P.; Urba,W. J.; Smith,J. W.; Margolin,K. A.; Mier,J. W.; Gollob,J. A.; Dutcher,J. P.; Atkins,M. B.Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 ;23(1):133-141
Farray,D.; Clark,J. I.Review.[comment] Clinical Advances in Hematology & Oncology 2005 ;3(5):427-428
Lathers,D. M.; Clark,J. I.; Achille,N. J.; Young,M. R.Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3 Cancer immunology, immunotherapy : CII 2004 ;53(5):422-430
Lindgren,V.; Paner,G. P.; Flanigan,R. C.; Clark,J. I.; Campbell,S. C.; Picken,M. M.Renal tumor with overlapping distal nephron morphology and karyotype. Archives of Pathology & Laboratory Medicine 2004 ;128(11):1274-1278
Duan,X.; Bruneval,P.; Hammadeh,R.; Fresco,R.; Eble,J. N.; Clark,J. I.; Vigneswaran,W. T.; Flanigan,R. C.; Picken,M. M.Metastatic juxtaglomerular cell tumor in a 52-year-old man. American Journal of Surgical Pathology 2004 ;28(8):1098-1102
Edelman,M. J.; Clark,J. I.; Chansky,K.; Albain,K.; Bhoopalam,N.; Weiss,G. R.; Giguere,J. K.; Kelly,K.; Crowley,J.; Gandara,D. R.Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel Clinical cancer research : an official journal of the American Association for Cancer Research 2004 ;10(15):5022-5026
Eisner,R. M.; Husain,A.; Clark,J. I.Case report and brief review: IL-2-induced myocarditis Cancer investigation 2004 ;22(3):401-404
Flanigan,R. C.; Campbell,S. C.; Clark,J. I.; Picken,M. M.Metastatic renal cell carcinoma Current Treatment Options in Oncology 2003 ;4(5):385-390
Campbell,S. C.; Flanigan,R. C.; Clark,J. I.Nephrectomy in metastatic renal cell carcinoma Current Treatment Options in Oncology 2003 ;4(5):363-372
Petruzzelli,G. J.; Knight,F. K.; Vandevender,D.; Clark,J. I.; Emami,B.Posterior marginal mandibulectomy in the management of cancer of the oral cavity and oropharynx. Otolaryngology - Head & Neck Surgery 2003 ;129(6):713-719
Clark,J. I.; Atkins,M. B.; Urba,W. J.; Creech,S.; Figlin,R. A.; Dutcher,J. P.; Flaherty,L.; Sosman,J. A.; Logan,T. F.; White,R.; Weiss,G. R.; Redman,B. G.; Tretter,C. P.; McDermott,D.; Smith,J. W.; Gordon,M. S.; Margolin,K. A.Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. Journal of Clinical Oncology 2003 ;21(16):3133-3140
Clark,J. I.; Kuzel,T. M.; Lestingi,T. M.; Fisher,S. G.; Sorokin,P.; Martone,B.; Viola,M.; Sosman,J. A.A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO 2002 ;13(4):606-613
Albain,K. S.; Crowley,J. J.; Turrisi,A. T.,3rd; Gandara,D. R.; Farrar,W. B.; Clark,J. I.; Beasley,K. R.; Livingston,R. B.Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 ;20(16):3454-3460
Ruzich,J. C.; Ciesla,M. C.; Clark,J. I.Response to paclitaxel and carboplatin in metastatic salivary gland cancer: a case report Head & neck 2002 ;24(4):406-410
Naeem,M.; Dahiya,M.; Clark,J. I.; Creech,S. D.; Alkan,S.Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis Human pathology 2002 ;33(12):1182-1187
Lathers,D. M.; Clark,J. I.; Achille,N. J.; Young,M. R.Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients Human immunology 2001 ;62(11):1282-1293
Nikitina,E. Y.; Clark,J. I.; Van Beynen,J.; Chada,S.; Virmani,A. K.; Carbone,D. P.; Gabrilovich,D. I.Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients Clinical cancer research : an official journal of the American Association for Cancer Research 2001 ;7(1):127-135
Lipton,J. M.; Federman,N.; Khabbaze,Y.; Schwartz,C. L.; Hilliard,L. M.; Clark,J. I.; Vlachos,A.; Diamond-Black Anemia RegistryOsteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry Journal of pediatric hematology/oncology 2001 ;23(1):39-44
Flaherty,L. E.; Atkins,M.; Sosman,J.; Weiss,G.; Clark,J. I.; Margolin,K.; Dutcher,J.; Gordon,M. S.; Lotze,M.; Mier,J.; Sorokin,P.; Fisher,R. I.; Appel,C.; Du,W.Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001 ;19(13):3194-3202
Almand,B.; Clark,J. I.; Nikitina,E.; van Beynen,J.; English,N. R.; Knight,S. C.; Carbone,D. P.; Gabrilovich,D. I.Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer Journal of immunology (Baltimore, Md.: 1950) 2001 ;166(1):678-689
Picken,M. M.; Curry,J. L.; Lindgren,V.; Clark,J. I.; Eble,J. N.Metanephric adenosarcoma in a young adult: morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses: a case report and review of the literature The American Journal of Surgical Pathology 2001 ;25(11):1451-1457
Clark,J. I.; Albain,K. S.Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma Cancer treatment and research 2001 ;105:149-170
Clark,J. I.; Hofmeister,C.; Choudhury,A.; Matz,G.; Collins,S.; Bastian,R.; Melian,E.; Emami,B.; Petruzzelli,G.Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma. Cancer 2001 ;92(9):2334-2340
Clark,J. I.; Kancharla,K.; Qamar,R.; Fisher,S.; Hantel,A.; Panganiban,J.; Millbrandt,L.; Albain,K. S.Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer Lung cancer (Amsterdam, Netherlands) 2001 ;34(2):271-277
Vaidya,A. M.; Petruzzelli,G. J.; Clark,J.; Emami,B.Patterns of spread in recurrent head and neck squamous cell carcinoma Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2001 ;125(4):393-396
Almand,B.; Resser,J. R.; Lindman,B.; Nadaf,S.; Clark,J. I.; Kwon,E. D.; Carbone,D. P.; Gabrilovich,D. I.Clinical significance of defective dendritic cell differentiation in cancer Clinical cancer research : an official journal of the American Association for Cancer Research 2000 ;6(5):1755-1766
Lingen,M. W.; Emami,B.; Clark,J. I.New therapeutic strategies for the treatment and prevention of head and neck cancer Expert opinion on investigational drugs 2000 ;9(12):2855-2872